Magnificent Seven stocks. Big Tech's runaway growth created gains, but headwinds are forming and some observers doubt the Mag ...
Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a ...
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
The Japanese stock market is significantly higher on Monday, reversing the losses in the previous session, with the Nikkei 225 moving ...
Japan’s Nikkei share average advanced on Monday, buoyed by gains on Wall Street and a weaker yen, even as a potential source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback